Pam Stetkiewicz

Chief Operating Officer at Arbor Biotechnologies, Inc.

Consumer Services

Health Technology

Commercial Services

Profile

Pam Stetkiewicz is currently the Director at ImmuneID, Inc. and the Chief Operating Officer at Arbor Biotechnologies, Inc. He has an undergraduate degree from the University of Rhode Island and a doctorate degree from The Johns Hopkins University.

Pam Stetkiewicz active positions

Companies	Position	Start
Arbor Biotechnologies, Inc. Arbor Biotechnologies, Inc. BiotechnologyHealth Technology Arbor Biotechnologies, Inc. engages in curating genetic biodiversity and discover novel protein functions from nature. The company was founded by David Arthur Svott, Winston Xia Yan, Feng Zhang and David R. Walt in 2016 and is headquartered in Cambridge, MA.	Chief Operating Officer	19/07/2021
ImmuneID, Inc. ImmuneID, Inc. Miscellaneous Commercial ServicesCommercial Services ImmuneID, Inc. is a precision immunology company that combines next-generation sequencing with protein display technologies to develop novel therapies for immune diseases. The company's proprietary platform identifies millions of antibody-target interactions to build the map of human immunity, which helps to improve and personalize patient diagnoses for precise treatments. The company was founded in 2020 by Longwood Fund and is headquartered in Boston, MA. James S. Scibetta has been the CEO of the company since 2021.	Director/Board Member	11/07/2022

All active positions of Pam Stetkiewicz

Training of Pam Stetkiewicz

The Johns Hopkins University	Doctorate Degree
University of Rhode Island	Undergraduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Pam Stetkiewicz's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	2
Arbor Biotechnologies, Inc. Arbor Biotechnologies, Inc. BiotechnologyHealth Technology Arbor Biotechnologies, Inc. engages in curating genetic biodiversity and discover novel protein functions from nature. The company was founded by David Arthur Svott, Winston Xia Yan, Feng Zhang and David R. Walt in 2016 and is headquartered in Cambridge, MA.	Health Technology
ImmuneID, Inc. ImmuneID, Inc. Miscellaneous Commercial ServicesCommercial Services ImmuneID, Inc. is a precision immunology company that combines next-generation sequencing with protein display technologies to develop novel therapies for immune diseases. The company's proprietary platform identifies millions of antibody-target interactions to build the map of human immunity, which helps to improve and personalize patient diagnoses for precise treatments. The company was founded in 2020 by Longwood Fund and is headquartered in Boston, MA. James S. Scibetta has been the CEO of the company since 2021.	Commercial Services